|
influenza |
11 |
|
adult |
7 |
|
aged |
7 |
|
astroviridae - classification - genetics - isolation and purification |
7 |
|
astroviridae infections - epidemiology - veterinary - virology |
7 |
|
betacoronavirus |
7 |
|
blood |
7 |
|
coronavirus |
7 |
|
coronavirus infection |
7 |
|
feces - virology |
7 |
|
fractional factorial design |
7 |
|
rna, viral - genetics |
7 |
|
rodent diseases - virology |
7 |
|
sars-cov-2 |
7 |
|
clade 2.3.4.4.b |
6 |
|
cross-reactive antibody response |
6 |
|
h7n9 |
6 |
|
influenza a(h1n1)pdm09 |
6 |
|
influenza a(h5n1) |
6 |
|
influenza polymerase |
6 |
|
neuraminidase inhibition antibody |
6 |
|
pandemic risk assessment |
6 |
|
respiratory infections |
6 |
|
viruses |
6 |
|
adjuvant |
5 |
|
antibody |
5 |
|
b cell |
5 |
|
china |
5 |
|
covid-19 |
5 |
|
deubiquitylases |
5 |
|
ha stem |
5 |
|
hong kong |
5 |
|
infection |
5 |
|
innate immune response |
5 |
|
polymerase |
5 |
|
rig-i signaling |
5 |
|
rna virus |
5 |
|
ubiquitylation |
5 |
|
coating |
4 |
|
molecular diagnosis |
4 |
|
pandemic h1n1 |
4 |
|
pb2 |
4 |
|
pb2-627 |
4 |
|
quantitative rt-pcr |
4 |
|
random mutagenesis |
4 |
|
bacterium culture |
2 |
|
controlled study |
2 |
|
cu2o |
2 |
|
cuo cupric oxide |
2 |
|
cuprous oxide |
2 |
|
disinfection |
2 |
|
escherichia coli |
2 |
|
filtration |
2 |
|
influenza virus |
2 |
|
influenza viruses |
2 |
|
nucleoproteins |
2 |
|
reassortment |
2 |
|
rna polymerases |
2 |
|
viricidal |
2 |
